Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Non-Current Deffered Revenue (2016)

Lisata Therapeutics (LSTA) has disclosed Non-Current Deffered Revenue for 4 consecutive years, with $4.6 million as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Non-Current Deffered Revenue changed N/A year-over-year to $4.6 million, compared with a TTM value of $4.6 million through Dec 2016, changed N/A, and an annual FY2016 reading of $4.6 million, changed N/A over the prior year.
  • Non-Current Deffered Revenue was $4.6 million for Q4 2016 at Lisata Therapeutics, up from $143734.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $4.6 million in Q4 2016 and bottomed at $143734.0 in Q3 2012.